21 May 2013
Keywords: novartis, spearheads, innovative, malaria, research, project, daniel
Article | 05 June 2006
Daniel Vasella, chief executive of Swiss drug major Novartis, has said that the Novartis Institute for Tropical Diseases (NITD) will ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
20 May 2013
© 2013 thepharmaletter.com